Plethico Pharmaceuticals Ltd
Fortune 500 2013
+ 3 More
+ 3 More
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Fortune 500 India
#494(2013)
#484(2012)
#440(2011)
#413(2010)
#494(2013)#484(2012)#440(2011)#413(2010)
Ranking Trend Fortune 500 India
Financial Data 2014
Revenue
2,110
(INR Cr)
Net Operating Income
2,060
(INR Cr)
Assets
3,028
(INR Cr)
Profit
111
(INR Cr)
Net Worth
1,614
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 2110 25.9% | 1677 1.1% | 1658 6.7% | 1553 20.1% | 1294 26.5% | 1022 - |
| Net Operating Income (INR Cr) | 2060 26.25% | 1632 4.78% | 1557 1.86% | 1529 22.38% | 1249 38.00% | 905 64.72% |
| Profit (INR Cr) | 111 9.1% | 101 -1.4% | 103 -57.9% | 244 12.7% | 217 75.8% | 123 - |
| Assets (INR Cr) | 3028 18.0% | 2567 4.8% | 2449 48.2% | 1652 10.0% | 1502 6.0% | 1418 - |
| Net Worth (INR Cr) | 1614 18.1% | 1367 0.2% | 1365 27.4% | 1071 20.4% | 890 20.9% | 736 24.1% |
| Employee Cost (INR Cr) | 155 35.7% | 114 8.9% | 105 -5.7% | 111 6.9% | 104 11.9% | 93 - |
| Interest Cost (INR Cr) | 175 | 67 | 89 | 40 | 35 | 23 |
| Cash & Bank Balance (INR Cr) | 34 | 32 | 110 | 41 | 50 | 46 |
| Total Debt (INR Cr) | 1391 | 1187 | 1069 | 581 | 612 | 682 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 5.3% | 6.1% | 6.2% | 15.7% | 16.8% | 12.1% |
| Profit As % Of Assets | 3.7% | 4.0% | 4.2% | 14.8% | 14.4% | 8.7% |
| Profit As % Of Networth | 6.9% | 7.4% | 7.5% | 22.8% | 24.4% | 16.8% |
| Interest Cost to EBITDA % | 59.5% | 41.6% | 58.4% | 11.7% | 15.0% | 35.4% |
| Debt to Equity Ratio | 0.86 | 0.87 | 0.78 | 0.54 | 0.69 | 0.93 |
| RONW | 5.9% | 7.4% | 12.9% | 24.9% | 26.7% | 28.7% |
| ROCE | 7.8% | 7.0% | 13.8% | 19.6% | 16.9% | 16.8% |